Please provide your email address to receive an email when new articles are posted on . Over the course of the past decades, our IOL technology has continued to improve, particularly with the ability ...

FORT WORTH, Texas--(BUSINESS WIRE)--April 25, 2005--Alcon, Inc., (NYSE:ACL) announced the launch of the AcrySof(R) ReSTOR(R) Intraocular Lens (IOL) at a press conference during the American Society of ...

The FineVision trifocal diffractive IOL has three focal points for far, near and intermediate vision. This study examines the outcome of bilateral implantation of this IOL and provides far, ...

Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Multifocal diffractive lenses can be used with confidence in patients who have previously ...

“As the global leader in eye care, we are committed to improving our technologies to advance patient outcomes through rigorous, world-class R&D—even with our leading products like PanOptix,” said Rob ...

Latest addition to Alcon’s intraocular lens (IOL) portfolio expands surgeons’ presbyopia-correcting IOL (PC-IOL) offerings Vivity X-WAVE technology delivers extended range of vision while maintaining ...

Intraocular lenses (IOLs), implanted in the eye as treatment for cataracts or myopia, are a growing global market in an ageing population, one estimated to be worth more than $4.5 billion by 2022.

The new, full-range TECNIS Odyssey intraocular lens aims to reduce dependence on glasses, with strong performance in any lighting, low light and high-contrast conditions offering cataract patients ...